| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenues | 319,716 | 214,414 | 148,079* | 149,011 |
| Cost of operations | 273,080 | 170,957 | 123,847* | 111,869 |
| Selling, general and administrative expenses | 33,695 | 44,379 | 23,796* | 29,782 |
| Research and development costs | 619 | 803 | 548* | 303 |
| Impairment of long-lived assets | 0 | 0 | 950* | 0 |
| Loss on asset disposals, net | -553 | 69 | -143* | -557 |
| Total costs and expenses | 307,947 | 216,070 | 149,284* | 142,511 |
| Operating income | 11,769 | -1,656 | -1,205* | 6,500 |
| Interest expense | 5,007 | 4,448 | 8,294* | 8,500 |
| Interest income | 750 | 640 | 147* | 356 |
| Gain on debt extinguishment | -31 | -28 | -759* | 1,730 |
| Benefit plans, net | -427 | -429 | 7,444* | 783 |
| Foreign exchange | 4 | -101 | -1,021* | -466 |
| Change in fair value of customer warrants | -5,858 | 70,242 | - | - |
| Other expense, net | -591 | -62 | -780* | -151 |
| Total other income (expense) | 1,410 | -73,812 | -18,152* | -7,814 |
| Income (loss) from continuing operations before income tax (benefit) expense | 13,179 | -75,468 | -19,357* | -1,314 |
| Income tax (benefit) expense | -1,076 | 4,154 | 900* | 1,028 |
| Income (loss) from continuing operations | 14,255 | -79,622 | -20,257* | -2,342 |
| Income (gain) from discontinued operations, net of tax | 0 | 2,677 | 19,198* | 37,434 |
| Net income (loss) attributable to stockholders | 14,255 | -76,945 | -1,059* | 35,092 |
| Less dividend on series a preferred stock | 3,715 | 3,715 | 3,714* | 3,715 |
| Net income (loss) attributable to stockholders of common stock, diluted | 10,540 | -80,660 | -4,773 | 31,377 |
| Basic EPS | 0.07 | -0.6 | -0.042 | 0.3 |
| Diluted EPS | 0.07 | -0.6 | -0.042 | 0.3 |
| Basic Average Shares | 142,331,000 | 133,754,000 | 114,497,000 | 103,047,000 |
| Diluted Average Shares | 154,513,000 | 133,754,000 | 114,497,000 | 103,047,000 |
Babcock & Wilcox Enterprises, Inc. (BWNB)
Babcock & Wilcox Enterprises, Inc. (BWNB)